Aberrantly methylated RUNX3 was found to be associated with the risk of multiple cancers, such as hepatocellular carcinoma [43], esophageal cancer [43], gastric carcinoma [44] and NSCLC [44]. This evidence concerns the gene RUNX3 and gastric carcinoma.